The Procter & Gamble Company (PG)

NYSE: PG · USD

$158

-0.84 (-0.5%)· Recorded snapshot

Awaryjny angielskiPL

Pokazujemy źródło angielskie podczas tłumaczenia

Ten raport nie został jeszcze przetłumaczony. Odśwież za kilka minut, gdy kolejka tłumaczeń go przetworzy.

StockMarketAgent Research · Analyzed 2026-09-09

Our latest published analysis: PG rated Reduce

The Procter & Gamble Company's published Reduce conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.

Fair value

$126 / share

Potential value

$204 / share

Upside to FV

-13.1%

from $158

Moat

5.5/10

Narrow

Read full analysis →View archive · 24mo

9-phase methodology · same model in each published edition

Market cap	$340.1B
Revenue (ttm)	87.9B
Net income (ttm)	15.7B
EPS (ttm)	$6.64
Shares out	2.3B
P/E (trailing)	23.9x
P/E (forward)	21.1x
Dividend	$4.35 (2.75%)
Volume	3,382,574
Beta	0.38

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 87.9B
Net income (ttm): 15.7B
EPS (ttm): $6.64
P/E (trailing): 23.9x
P/E (forward): 21.1x
Market cap: $340.1B

Item	P1	P2	P3	P4	P5	Trend
Period	2022-06-30	2023-06-30	2024-06-30	2025-06-30	2026-06-30	Trend
Revenue	$80.19B	$82.01B	$84.04B	$84.28B	$87.03B	+2.1%
Gross profit	$38.03B	$39.25B	$43.19B	$43.12B	$43.67B	+3.5%
Operating income	$17.81B	$18.13B	$18.55B	$20.45B	$19.75B	+2.6%
Net income	$14.74B	$14.65B	$14.88B	$15.97B	$16.05B	+2.1%
EPS (diluted)	$5.81	$5.90	$6.02	$6.51	$6.62	+3.3%
EBITDA	$21.24B	$21.77B	$22.58B	$23.92B	$21.25B	+0.0%
R&D	$2.00B	$2.00B	$2.00B	$2.10B	$2.10B	+1.2%
SG&A	$20.22B	$21.11B	$23.31B	$22.67B	$23.92B	+4.3%

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ABBV	AbbVie Inc.	505.6B	80.8x	7.9x	17.7%	+3.7%	+29.1%	Sprzedaj
ABT	Abbott Laboratories	177.6B	38.2x	3.7x	7.2%	+2.7%	-17.2%	Redukuj
ACN	Accenture plc	144.3B	18.0x	2.0x	27.9%	+8.0%	+0.4%	Trzymaj
ADM	Archer-Daniels-Midland Company	37.3B	21.2x	0.5x	5.0%	+1.8%	+28.5%	Redukuj
BF.B	Brown-Forman Corporation Class B	12.7B	17.9x	3.3x	14.3%	+1.6%	+0.4%	Kupuj
CAG	Conagra Brands, Inc.	6.6B	—	0.6x	9.2%	+0.2%	-18.9%	Zdecydowanie kupuj

Base and Bull scenarios

Base60%

Price target

$126.47

-13.1% from spot

The base case is modest compounding, not a sharp reacceleration. A miss against either annual revenue anchor would disconfirm it by FY2028.

Revenue meets the explicit FY2027 and FY2028 annual anchors.
Margins remain near FY2026 levels without assumed expansion.
Cash conversion remains strong enough to fund recurring investment.

Bull20%

Price target

$204.04

+40.2% from spot

Upside requires FY2028 earnings to meet the forecast, FY2026 cash generation to persist, and the FY2024-to-FY2026 decline in diluted shares to continue. A miss against the FY2028 forecast or weaker operating cash would disconfirm this path.

FY2028 earnings reach the upper part of the analyst forecast range.
Shipment and consumption gaps clear across major regions.
High-velocity products preserve retailer relevance and margins.

Sensitivity: Ke × terminal growth

The highlighted cell is Fair value when every assumption sits at its base level ($126.47). Each row and column shows what Fair value becomes when one assumption moves.

Ke ↓ / g →	1.5%	2.0%	2.5%	3.0%	3.5%
5.0%	$151	$163	$180	$204	$244
6.0%	$131	$138	$146	$158	$173
7.0%	$117	$121	$126	$133	$141
8.0%	$107	$110	$113	$117	$122
9.0%	$99.4	$102	$104	$107	$110

Scorecard

Published factor rows and weighted composite

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E21.1

P25 n/aP50 n/aP75 n/a

Trailing P/E22.1

P25 n/aP50 n/aP75 n/a

ROE29.6

P25 n/aP50 n/aP75 n/a

ROIC21.9

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All PG indicators

Market & fundamental data

Available fields

291

Groups with data

Currency

USD

Showing 291 of 291 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0000080424
Company name	The Procter & Gamble Company
Country	United States
Country code	US
CUSIP number	742718109
Earnings date	2026-10-22
Earnings time	bmo
Employees	104,000
Employees change	-5,000
Employees growth	-4.59%
Enterprise value	$390.7B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-09
Fiscal year end	June
Founded	1837
In index	SP500, DOW30
Industry	Household & Personal Products
Is primary listing	Yes
Is SPAC	No
ISIN number	US7427181091
Last 10-K release date	2026-08-04
Last earnings date	2026-10-22
Last refreshed	2026-10-28
Last stock split date	2004-06-21
Last stock split type	Forward
Market cap	$367.1B
Market cap category	Mega-Cap
Next earnings date	2027-01-21
Options	Yes
Price	$158.39
Price currency	USD
Sector	Consumer Staples
SIC code	2840
Stock price date	2026-10-28
Symbol	PG
U.S. state	Ohio
Website	https://www.pginvestor.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	22.96x
Average P/E ratio (10Y)	27.55x
Average P/E ratio (3Y)	23.96x
Average P/E ratio (5Y)	24.22x
Earnings yield	4.19%
EV/Earnings	24.94x
EV/EBIT	17.94x
EV/EBITDA	15.64x
EV/FCF	25.59x
EV/Sales	4.46x
FCF / EV yield	3.91%
FCF yield	4.16%
Forward EV/Sales	4.33x
Forward P/E	22.37x
Forward P/S	4.07x
Graham number	59.17158
Graham upside	-62.83%
Industry forward P/E	20.32x
Industry P/E	23.22x
Lynch fair value	$33.18
Lynch upside	-79.16%
P/(FCF - SBC) ratio	24.86x
P/(OCF - SBC) ratio	19.01x
P/B ratio	6.79x
P/E ratio	23.87x
P/FCF ratio	24.05x
P/OCF ratio	18.53x
P/S ratio	4.2x
PEG ratio	4.84x
Price/EBITDA ratio	14.7x
Sector forward P/E	21.3x
Sector P/E	28.26x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	24.89%
EBITDA margin	28.54%
Effective tax rate	20.85%
FCF margin	17.45%
Gross margin	50.6%
Operating margin	24.89%
Pretax margin	23.16%
Profit margin	18.23%
Profit per employee	$151,308
Profitable quarters	29
Profitable years	33
Revenue per employee	$845,404
ROA	10.49%
ROA (5Y)	10.36%
ROCE	24.83%
ROE	29.61%
ROE (5Y)	31.05%
ROIC	21.89%
ROIC (5Y)	21.54%
SBC / revenue	0.57%
Tax / revenue	4.83%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-3.14%
EPS growth (Q)	0.83%
EPS growth (QoQ)	57.37%
EPS growth 10Y	5.88%
EPS growth 3Y	2.56%
EPS growth 5Y	3.93%
EPS growth quarters	1
EPS growth years	7
FCF growth	2.66%
FCF growth (Q)	4.59%
FCF growth (QoQ)	7.13%
FCF growth 3Y	1.7%
FCF growth 5Y	0.12%
Gross profit growth	2.29%
Gross profit growth (Q)	1.82%
Gross profit growth 3Y	2.75%
Gross profit growth 5Y	2.7%
Net income growth	-4.4%
Net income growth (Q)	-0.4%
Net income growth (QoQ)	56.87%
Net income growth 3Y	1.71%
Net income growth 5Y	2.56%
Net income growth years	3
OCF growth	5.24%
OCF growth (Q)	6.64%
OCF growth (QoQ)	12.4%
OCF growth 10Y	2.93%
OCF growth 3Y	4.04%
OCF growth 5Y	1.73%
Operating income growth	0.96%
Operating income growth (Q)	4.86%
Operating income growth 3Y	3.08%
Operating income growth 5Y	3.38%
Revenue growth	3.52%
Revenue growth (Q)	3.98%
Revenue growth (QoQ)	9.77%
Revenue growth 10Y	3.02%
Revenue growth 3Y	1.83%
Revenue growth 5Y	2.65%
Revenue growth quarters	6
Revenue growth years	9

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-4.6B
Depreciation and amortization	$3.2B
EBIT	$21.9B
EBITDA	$25.1B
EPS	$6.64
FCF per share	$6.62
Financing cash flow	$-11.1B
Free cash flow	$15.3B
Free cash flow minus SBC	$14.8B
Gross profit	$44.5B
Income taxes	$4.2B
Investing cash flow	$-4.5B
Net borrowing	$3.3B
Net cash flow	$4.2B
Net income	$15.7B
Operating cash flow minus SBC	$19.4B
Operating income	$21.9B
Revenue	$87.9B
Stock-based compensation	$501M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	5.2
Book value per share	$23.45
Debt / EBITDA	1.53
Debt / equity	0.7
Debt / FCF	2.54
Goodwill	$41.2B
Interest coverage	24.23
Long-term assets	$100.6B
Long-term liabilities	$32.8B
Net cash (debt)	$-23.6B
Net cash / market cap	-6.39%
Net debt / EBITDA	0.94
Net debt / equity	0.43
Net debt / FCF	1.54
Piotroski F-Score	7
Property, plant and equipment	$25.5B
Shareholders' equity	$55.3B
Tangible book value	$-8.2B
Tangible book value per share	$-3.54
Total assets	$133.1B
Total cash	$15.4B
Total debt	$38.9B
Total liabilities	$77.8B
WACC	5.9%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.67
Current assets	$32.5B
Current liabilities	$45B
Current ratio	0.72
Inventory turnover	5.32
Net working capital	$-10.8B
Quick ratio	0.49
Working capital	$-12.5B
Working capital turnover	-7.53

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.31%
Dividend growth	3.48%
Dividend growth (10Y)	4.93%
Dividend growth (3Y)	4.98%
Dividend growth (5Y)	4.92%
Dividend growth years	70
Dividend payment date	2026-11-16
Dividend payment years	70
Dividend payout frequency	Quarterly
Dividend per share	$4.35
Dividend yield	2.75%
Ex-dividend date	2026-10-23
FCF payout ratio	65.79%
Last dividend	$1.09
Payout ratio	65.61%
Shareholder yield	4.04%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	83.02%
10Y return CAGR	9.15%
10Y total return	140.05%
150-day SMA	$147.11
15Y price change	142.81%
15Y return CAGR	9.18%
15Y total return	273.5%
1D price change	-0.53%
1M price change	8.36%
1M total return	9.08%
1W price change	-0.54%
1W total return	0.12%
1Y price change	4.43%
1Y return CAGR	7.46%
1Y total return	7.46%
20-day SMA	$154.51
200-day SMA	$148.77
20Y price change	149.31%
20Y return CAGR	7.69%
20Y total return	340.03%
3M price change	6.61%
3M total return	7.32%
3Y price change	7.68%
3Y return CAGR	5.24%
3Y total return	16.56%
50-day SMA	$149.30
50-day SMA vs 200-day SMA	50over200
52-week high	$167.25
52-week high date	2026-02-27
52-week low	$137.62
52-week low date	2026-01-07
5Y price change	11.73%
5Y return CAGR	4.91%
5Y total return	27.09%
6M price change	6.78%
6M total return	8.29%
All-time high	$180.43
All-time high date	2024-11-27
All-time low	$1.26
All-time low date	1970-05-26
Average true range (ATR)	$2.98
Average volume	9.8M
Beta (1Y)	0.14
Beta (2Y)	0.22
Beta (5Y)	0.38
Change from 52-week high	-5.3%
Change from 52-week low	15.09%
Change from all-time high	-12.18%
Change from all-time low	12,496.18%
Change from open	0.25%
Day's gap	-0.78%
Dollar volume	$535.8M
High price	$159.54
Low price	$157.49
Monthly RSI	53.38
Open price	$157.99
Position in 52-week range	43.9%
Premarket change	-0.89%
Premarket close	$159.23
Premarket price	$157.82
Premarket volume	15.3K
Previous close	$159.23
Price vs 150-day SMA	7.71%
Price vs 20-day SMA	2.56%
Price vs 200-day SMA	6.52%
Price vs 50-day SMA	6.14%
Relative volume	0.35
RSI	58.2
Sharpe ratio	0.26
Sharpe ratio (3Y)	0.14
Sharpe ratio (5Y)	0.15
Sortino ratio	0.68
Sortino ratio (3Y)	0.51
Sortino ratio (5Y)	0.51
Volume	3.4M
Weekly RSI	63.06
YTD price change	10.57%
YTD total return	13.78%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2.3B
Float percentage	99.81%
Shares change (QoQ)	-0.23%
Shares change (YoY)	-1.31%
Shares held by insiders	0.06%
Shares held by institutions	71.29%
Shares outstanding	2.3B
Short % of float	1.06%
Short % of shares	1.05%
Short ratio	3 days

Other indicators

Additional ticker metrics that do not fit the primary research groupings.

Metric	Value
Page views	341

Deeper analysis on PG

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Quote this valuation with its source: Fair value, Potential value and the price at analysis.

Frequently asked questions

About this PG report

What is the latest published PG stock rating?

The Procter & Gamble Company is shown with Reduce in the latest published report, analyzed 2026-09-09. The hub links directly to the full analysis surface where the dated rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full PG analysis?

The full latest published report, analyzed 2026-09-09, lives at /stocks/PG/analysis. The bare ticker page summarizes that read and links to each analysis tab; earlier editions remain under /analysis/archive.

What fair value is used for PG?

The latest published report analyzed 2026-09-09 gives PG a fair value of USD 126 and a potential value of USD 204. These are dated research outputs, not live market prices; review the valuation assumptions, sensitivity analysis, and material risks before making a decision.

How often is the PG page updated?

The hub selects the latest published stock report regardless of age and displays its analysis date (2026-09-09). Separately sourced market data is labeled with its own recorded timestamp and is never inferred from the report.

ReducePG · Fair value $126-13.1%

Read full analysis →

The Procter & Gamble Company (PG)

Our latest published analysis: PG rated Reduce

Price

Financial snapshot

Fair-value bridge

Latest news · PG

Valuation

Profitability

Balance sheet

Trading

Base and Bull scenarios

Sensitivity: Ke × terminal growth

Scorecard

Next earnings

Sector percentile context

All PG indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on PG

Frequently asked questions

Historia rekomendacji

Category	Score	Reading
Valuation	3.0
Management	6.5
Balance Sheet	4.0
Profitability	7.5
Revenue Growth	4.5
Risk Assessment	6.0
Competitive Moat	5.5
Earnings Quality	6.0
Capital Efficiency	7.5